Advanced Search

Technical Analysis for TLIS - Talis Biomedical Corporation

Grade Last Price % Change Price Change
F 9.77 -11.42% -1.26
TLIS closed down 11.42 percent on Thursday, May 13, 2021, on 44 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical TLIS trend table...
Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -11.42%
Older End-of-Day Signals for TLIS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band about 6 hours ago
Possible Inside Day about 6 hours ago
Down 10% about 6 hours ago
Lower Bollinger Band Support about 8 hours ago
Down 1 ATR about 9 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Talis Biomedical Corporation develops a diagnostic platform that offers senior care facilities and laboratory testing services. Talis Biomedical Corporation was formerly known as Talis Biomedical, Inc. and changed its name to Talis Biomedical Corporation in February 2018. The company was founded in 2010 and is based in Menlo Park, California with an additional office in Chicago, Illinois.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Lab Testing Information Science Diagnostics

Is TLIS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 12 Have Insiders Been Buying Talis Biomedical Corporation (NASDAQ:TLIS) Shares?
May 12 Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript
May 11 Talis Biomedical EPS of -$4.61
May 11 Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
May 11 Talis Biomedical Corp to Host Earnings Call
May 11 Earnings Scheduled For May 11, 2021
May 4 Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021
Apr 28 Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
Mar 26 The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Mar 18 Talis Appoints Jeryl Hilleman to Board of Directors
See more TLIS news...

Indicators

Indicator Value
52 Week High 33.9
52 Week Low 9.43
Average Volume 210,765
200-Day Moving Average 0.00
50-Day Moving Average 13.02
20-Day Moving Average 11.77
10-Day Moving Average 11.10
Average True Range 1.03
ADX 22.66
+DI 10.71
-DI 25.82
Chandelier Exit (Long, 3 ATRs ) 12.20
Chandelier Exit (Short, 3 ATRs ) 12.51
Upper Bollinger Band 13.61
Lower Bollinger Band 9.92
Percent B (%b) -0.04
BandWidth 31.34
MACD Line -0.88
MACD Signal Line -0.80
MACD Histogram -0.0736
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.75
Resistance 3 (R3) 11.97 11.53 11.42
Resistance 2 (R2) 11.53 11.03 11.42 11.31
Resistance 1 (R1) 10.65 10.71 10.43 10.43 11.20
Pivot Point 10.21 10.21 10.10 10.10 10.21
Support 1 (S1) 9.33 9.71 9.11 9.11 8.34
Support 2 (S2) 8.89 9.39 8.78 8.23
Support 3 (S3) 8.01 8.89 8.12
Support 4 (S4) 7.79